Bruker (BRKR) Capital Expenditures (2010 - 2026)

Bruker (BRKR) has reported Capital Expenditures for 17 consecutive years, with $28.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 35.21% year-over-year to $28.8 million; the trailing twelve-month figure through Jun 2026 stood at $96.5 million (down 17.24% YoY), and the FY2025 full-year result was $90.8 million, down 21.25% from the prior year.
• Capital Expenditures climbed to $28.8 million in Q2 2026 per BRKR's latest filing, from $24.2 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $57.7 million in Q3 2022 and bottomed at $17.9 million in Q2 2022.
• Historically, Capital Expenditures has averaged $27.5 million across 5 years, with a median of $24.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Capital Expenditures soared 253.99% in 2022, then tumbled 53.38% in 2023.
• Over 5 years, Capital Expenditures stood at $34.6 million in 2022, then fell by 8.96% to $31.5 million in 2023, then gained by 16.51% to $36.7 million in 2024, then sank by 38.42% to $22.6 million in 2025, then grew by 27.43% to $28.8 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $28.8 million, $24.2 million, and $22.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.